COULTER DIAGNOSTICS, INC. – Trademark Portfolio
Entity Type: 03
COULTER DIAGNOSTICS, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LYSE S. The owner is based in MIAMI SPRINGS, FL.
81 HOOK SQUARE
MIAMI SPRINGS, FL 33166
Showing of trademarks Trademarks
Trademark Classifications
COULTER DIAGNOSTICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does COULTER DIAGNOSTICS, INC. have?
COULTER DIAGNOSTICS, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 cancelled.
What trademark classes does COULTER DIAGNOSTICS, INC. file in?
COULTER DIAGNOSTICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are COULTER DIAGNOSTICS, INC.'s most well-known trademarks?
COULTER DIAGNOSTICS, INC.'s registered trademark portfolio includes well-known marks such as LYSE S. These are among 1 currently registered trademark in the portfolio.
What is COULTER DIAGNOSTICS, INC.'s trademark registration success rate?
COULTER DIAGNOSTICS, INC. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.